Case Report: Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination

Vaccination is one of the cornerstones in the efforts towards ending the coronavirus disease 2019 (COVID-19) pandemic. However, several adverse effects of COVID-19 vaccination have been identified. Pityriasis rosea (PR)-like eruption is a rare cutaneous complication of immunization. To the best of o...

Descripción completa

Detalles Bibliográficos
Autores principales: Leerunyakul, Kanchana, Pakornphadungsit, Kallapan, Suchonwanit, Poonkiat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452904/
https://www.ncbi.nlm.nih.gov/pubmed/34557507
http://dx.doi.org/10.3389/fmed.2021.752443
_version_ 1784570173025419264
author Leerunyakul, Kanchana
Pakornphadungsit, Kallapan
Suchonwanit, Poonkiat
author_facet Leerunyakul, Kanchana
Pakornphadungsit, Kallapan
Suchonwanit, Poonkiat
author_sort Leerunyakul, Kanchana
collection PubMed
description Vaccination is one of the cornerstones in the efforts towards ending the coronavirus disease 2019 (COVID-19) pandemic. However, several adverse effects of COVID-19 vaccination have been identified. Pityriasis rosea (PR)-like eruption is a rare cutaneous complication of immunization. To the best of our knowledge, there have been no reports of PR-like eruptions following inoculation with Oxford/AstraZeneca ChAdOx1 nCoV-19 (AZD1222) vaccine. Here, we described a case of PR-like eruption that developed 14 days after Oxford/AstraZeneca vaccination in a 52-year-old Thai woman with glioblastoma. Treatment with topical 0.1% triamcinolone acetonide twice per day showed partial response after seven days. Despite this rare complication, our report highlights that the presence of PR-like eruption is not a contraindication for subsequent vaccinations.
format Online
Article
Text
id pubmed-8452904
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-84529042021-09-22 Case Report: Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination Leerunyakul, Kanchana Pakornphadungsit, Kallapan Suchonwanit, Poonkiat Front Med (Lausanne) Medicine Vaccination is one of the cornerstones in the efforts towards ending the coronavirus disease 2019 (COVID-19) pandemic. However, several adverse effects of COVID-19 vaccination have been identified. Pityriasis rosea (PR)-like eruption is a rare cutaneous complication of immunization. To the best of our knowledge, there have been no reports of PR-like eruptions following inoculation with Oxford/AstraZeneca ChAdOx1 nCoV-19 (AZD1222) vaccine. Here, we described a case of PR-like eruption that developed 14 days after Oxford/AstraZeneca vaccination in a 52-year-old Thai woman with glioblastoma. Treatment with topical 0.1% triamcinolone acetonide twice per day showed partial response after seven days. Despite this rare complication, our report highlights that the presence of PR-like eruption is not a contraindication for subsequent vaccinations. Frontiers Media S.A. 2021-09-07 /pmc/articles/PMC8452904/ /pubmed/34557507 http://dx.doi.org/10.3389/fmed.2021.752443 Text en Copyright © 2021 Leerunyakul, Pakornphadungsit and Suchonwanit. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Leerunyakul, Kanchana
Pakornphadungsit, Kallapan
Suchonwanit, Poonkiat
Case Report: Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination
title Case Report: Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination
title_full Case Report: Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination
title_fullStr Case Report: Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination
title_full_unstemmed Case Report: Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination
title_short Case Report: Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination
title_sort case report: pityriasis rosea-like eruption following covid-19 vaccination
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452904/
https://www.ncbi.nlm.nih.gov/pubmed/34557507
http://dx.doi.org/10.3389/fmed.2021.752443
work_keys_str_mv AT leerunyakulkanchana casereportpityriasisrosealikeeruptionfollowingcovid19vaccination
AT pakornphadungsitkallapan casereportpityriasisrosealikeeruptionfollowingcovid19vaccination
AT suchonwanitpoonkiat casereportpityriasisrosealikeeruptionfollowingcovid19vaccination

Ejemplares similares